APD356

DRUG2 trials

Sponsors

Eisai Inc.

Conditions

Obesity

Phase 2

Safety and Efficacy of APD356 in the Treatment of Obesity

CompletedNCT00104507

Eisai Inc.Obesity

Start: 2004-12-31End: 2005-05-31Target: 400Updated: 2019-09-12

Safety and Efficacy of APD356 in the Treatment of Obesity

CompletedNCT00116740

Eisai Inc.Obesity

Start: 2005-06-30End: 2005-11-30Target: 400Updated: 2019-09-12